Please wait...
Please wait...

Franklin India Life Stage Fund Of Funds - 30's Plan

'Hi, I came across this interesting fund from Franklin Templeton. Check it out!'
Annualised Returns As of 31/12/2021
Minimum Investment/Multiples for Fresh Purchase (INR)


Additional Investment/Multiples thereof (INR)


Over 350 Unique Investors (As of 31/12/2021)
Why should you invest in Franklin India Life Stage Fund Of Funds - 30's Plan?
  • Franklin India Life Stage Fund of Funds- 30s Plan is a “fund of funds” scheme offering life stage based solutions under different plans with varying asset allocation as per age-groups
  • As the name suggests , the fund is suitable for investors within the age group of 30-40 years
  • The fund invests in a mix of equity and fixed income funds of Franklin Templeton Mutual Fund as per stated asset allocation
What are the “Tax Benefits” of investing in this fund?**
  • Long term capital gains (LTCG) tax @20% (plus surcharge, if applicable and cess) with indexation if units held for more than 36 months
  • Short term capital gains (STCG) tax at the income tax slab rate if units are held for less than 36 months
  • Income distribution cum capital withdrawal (IDCW) shall be taxable in the hands of investors and the mutual fund will deduct TDS @10% for resident investors and @20% (plus applicable surcharge and cess) for non-resident investors before payouts/re-investment. However, investors can claim tax-credit of TDS deducted at the time of filing their annual return.
  • In case of an investor being NRI, LTCG tax are chargeable @ 10% (plus surcharge, if applicable and cess) without indexation relating to units redeemed from unlisted schemes.
What is the “Ideal Investment Horizon” while investing in this fund?

The recommended investment horizon is “5 years or more”

Alternative To
  • Multi Asset Investments

Suitable For
  • Retirement Corpus

  • Long Term Wealth Creation

  • Education Corpus

Fund Video

Franklin India Life Stage Fund Of Funds - 30's Plan is a hybrid fund. It is a fund of funds offering life stages solutions with different plans of varying asset allocation. This fund is mainly for the people within the age group of 30-40 years. It is suitable for long term wealth creation. The ideal investment horizon for this fund is 5 years or more. To know more about Franklin India Life Stage Fund Of Funds - 30's Plan, watch the video below.

Fund Information

  • Inception 01/12/2003
  • Entry Load Nil
  • Exit Load In respect of each purchase of units - 0.75% if redeemed within 1 year of allotment
  • NAV in INR as on 17/01/2022
  • 30s Plan-Growth 80.7250
  • 30s Plan-IDCW 24.1870
  • Direct-Growth 85.0300
  • Direct-IDCW 26.0082
  • Additional Fund Information as on 31/12/2021
  • Fund Size in INR (CR) 5.77
  • Expense Ratio [#] 1.36
  • Expense Ratio (Direct) [#] 0.93
  • Benchmark(s) 45% S&P BSE Sensex + 10% Nifty 500 + 45% Crisil Composite Bond Fund IndexINST2::Nifty 50
  • Fund Manager Paul S Parampreet
Product Label
This product is suitable for Investors who are seeking*:
  • Long term capital appreciation
  • A fund of funds investing in equity and debt mutual funds

*Investors should consult their financial distributors if in doubt about whether the product is suitable for them.

Riskometer of Benchmark: 45% S&P BSE Sensex + 10% Nifty 500 + 45% Crisil Composite Bond Fund Index


[##]IDCW - Income Distribution cum Capital Withdrawal

[#] The rates specified are the actual expenses charged as at the end of the month. The above ratio includes the GST on Investment management fees. The above expense also includes proportionate charge in respect sales of beyond T-30 cities subject to maximum of 30 bps on daily net assets wherever applicable.

** The information given here is neither a complete disclosure of every material fact of Income-tax Act 1961 nor does it constitute tax or legal advice. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.